Gwrthrychau elusennol
3.1 THE OBJECTS OF THE CIO ARE:
(A) TO ADVANCE THE EDUCATION OF THE PUBLIC IN GENERAL AND TO PROMOTE MEDICAL RESEARCH RELATED TO NEUROENDOCRINE CANCERS (PARTICULARLY PARAGANGLIOMA AND PHEOCHROMOCYTOMA, WITH SPECIAL REGARD TO MALIGNANT PARAGANGLIOMAS CAUSED BY THE SDHB MUTATION) FOR THE PUBLIC BENEFIT.
(B) TO ADVANCE HEALTH BY SUPPORTING EFFORTS TO IMPROVE TREATMENT OPTIONS FOR PEOPLE WITH NEUROENDOCRINE CANCERS.
(C) TO ADVANCE SCIENCE BY INCREASING THE EXISTING BODY OF KNOWLEDGE IN RELATION TO THE UNDERSTANDING, DIAGNOSIS, MANAGEMENT AND TREATMENT OF NEUROENDOCRINE CANCERS.
